Cristóbal Richart

Universitat Rovira i Virgili — Spain

Medicine · Health Sciences

48h-index9.1kcitations307works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(49), Adipokines, Inflammation, and Metabolic Diseases(46), Adipose Tissue and Metabolism(18), Diet, Metabolism, and Disease(18), Diabetes and associated disorders(17)

Publications305 total

Serum and liver proteome in women with morbid obesity and metabolic dysfunction-associated steatotic liver disease
Journal of Laboratory Medicine·2026Open Access
The genome sequence of the red-legged partridge, Alectoris rufa Linnaeus 1758
F1000Research·2025Open Access
Abstract LB383: Preclinical efficacy of an innovative therapeutic cancer vaccine: A new era for immunotherapy
Cancer Research·2025
Untargeted lipidomic analysis of metabolic dysfunction-associated steatohepatitis in women with morbid obesity
PLoS ONE·2025· 2 citedOpen Access
Exploring the role of fatty acid esters of hydroxy fatty acids in metabolic dysfunction-associated steatotic liver disease in morbidly obese women
Digestive and Liver Disease·2024Open Access
Circulating proteomic profiles in women with morbid obesity compared to normal-weight women
Journal of Proteomics·2024· 2 citedOpen Access
Unraveling the Lack of Correlation between RBP4 and MASLD: Insights from Gene Expression and Serum Level Analysis
2024Open Access
Proteomics profile of serum and liver samples in women with morbid obesity and metabolic dysfunction-associated steatohepatitis
2024Open Access
Circulating Proteomic Profiles in Women with Morbid Obesity Compared to Normal-Weight Women
2024Open Access
Long-read de novo assembly of the red-legged partridge (Alectoris rufa) genome
Scientific Data·2024· 1 citedOpen Access
Hybrid assembly and comparative genomics unveil insights into the evolution and biology of the red-legged partridge
Scientific Reports·2024· 3 citedOpen Access
Proteomics profile of serum and liver samples in women with morbid obesity and metabolic dysfunction-associated steatohepatitis
2024
Untargeted Lipidomics Analysis in Metabolic Dysfunction-Associated Steatohepatitis Associated with Morbid Obesity
2024Open Access
Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction‐associated steatotic liver disease
European Journal of Clinical Investigation·2024· 22 citedOpen Access
Exploring the Role of Fatty Acid Esters of Hydroxy Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease in Morbid Obese Women
Research Square (Research Square)·2024Open Access
Untargeted lipidomics analysis in women with morbid obesity and type 2 diabetes mellitus: A comprehensive study
PLoS ONE·2024· 8 citedOpen Access
LC/MS untargeted lipidomics analysis in women with morbid obesity and type 2 diabetes mellitus: a comprehensive study
Endocrine Abstracts·2024· 2 cited
Long-read <i>de novo</i> assembly of the red-legged partridge ( <i>Alectoris rufa</i> ) genome
2024· 1 citedOpen Access
An almost chromosome-level assembly and annotation of the <i>Alectoris rufa</i> genome
2024Open Access
Platelet‐associated biomarkers in nonalcoholic steatohepatitis: Insights from a female cohort with obesity
European Journal of Clinical Investigation·2023· 11 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Joan Vendrell(19), Montserrat Broch(16), Cristina Gutiérrez(16), José Manuel Fernández‐Real(16), Teresa Auguet(15), Carmen Aguilar(15), Wifredo Ricart(11), Mercè Hernández(9), Fàtima Sabench(9), Daniel Del Castillo(9), Ximena Terra(8), José Antonio Porras(8), S. Martínez(8), Alfredo Bardajı́(6), Ana Megía(6), Núria Vilarrasa(5), I Simón(5), José Manuel Gómez(4), Francesc Vidal(4), Roser Casamitjana(4)